The Louvain researchers performed a blood test on 1002 patients aged 65 years and began testing possible tumors in the genetic material. Hodgkin's disease was found in five people. A sixth patient had warning signs of blood cancer.
The fact that the test identifies patients with Hodgkin's disease demonstrates the new possibilities that the test offers. The originality of the study is to allow the detection of the disease even before the onset of symptoms. Further research should now analyze whether it is possible to conduct a test on a large scale.